Revenue of $6.3 million and $18.8 million for the three- and nine-month period ending September 30, 2024, representing a 0.34 ...

The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 ...

Around 1,200 workers in Plymouth hospitals have been awarded a wage rise and back pay following strike action earlier this ...

Chronic fatigue and long Covid remain poorly understood, but Dr Perrin’s unusual techniques are having surprisingly positive ...

Receiving a cancer diagnosis can be life-changing and overwhelming, and questions about where to seek treatment and its cost ...